BioMarin Pharmaceutical (BMRN) Tops Q1 Earnings Estimates BioMarin (BMRN) delivered earnings and revenue surprises of 18.33% and 0.14%, respectively, for the quarter ended March 2024. Do the…
GMAB: 3 Biotech Stocks Gaining Altitude and Interest This year, the biotech industry anticipates a resurgence with increased M&A, FDA approvals, and AI-driven innovations. Given the industry’s rosy…